| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
37,918 |
31,749 |
$2.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,322 |
23,703 |
$1.48M |
| 95144 |
|
3,734 |
427 |
$505K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,805 |
356 |
$425K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,800 |
3,744 |
$401K |
| 99215 |
Prolong outpt/office vis |
2,128 |
1,974 |
$212K |
| 95923 |
|
937 |
903 |
$95K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
395 |
388 |
$84K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,930 |
5,216 |
$75K |
| 95921 |
|
929 |
898 |
$63K |
| 95816 |
|
185 |
88 |
$39K |
| 93922 |
|
550 |
534 |
$36K |
| 93923 |
|
310 |
295 |
$31K |
| 99457 |
|
808 |
768 |
$29K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
328 |
321 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,612 |
1,539 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
289 |
282 |
$24K |
| 92546 |
|
275 |
209 |
$20K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
246 |
245 |
$18K |
| 99454 |
|
482 |
461 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
226 |
225 |
$17K |
| 99458 |
|
520 |
452 |
$14K |
| 99205 |
Prolong outpt/office vis |
91 |
89 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
118 |
116 |
$10K |
| 20611 |
|
136 |
70 |
$9K |
| 92540 |
|
110 |
105 |
$9K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
5,167 |
4,579 |
$9K |
| G0247 |
Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails |
119 |
112 |
$7K |
| 90658 |
|
589 |
550 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
165 |
163 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
388 |
250 |
$5K |
| 0012A |
|
157 |
150 |
$5K |
| G0245 |
Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education |
90 |
89 |
$5K |
| 95117 |
|
513 |
308 |
$5K |
| 0011A |
|
155 |
147 |
$4K |
| 99385 |
|
42 |
42 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
122 |
112 |
$3K |
| 0064A |
|
77 |
70 |
$3K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
23 |
16 |
$3K |
| 96112 |
|
29 |
13 |
$2K |
| 92551 |
|
248 |
241 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
97 |
89 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
88 |
86 |
$2K |
| 96132 |
|
20 |
20 |
$2K |
| 92547 |
|
199 |
191 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
111 |
101 |
$1K |
| 90686 |
|
811 |
689 |
$786.65 |
| 99453 |
|
58 |
57 |
$777.59 |
| 99173 |
|
154 |
151 |
$361.74 |
| 36415 |
Collection of venous blood by venipuncture |
28 |
28 |
$206.70 |
| 82962 |
|
119 |
102 |
$186.12 |
| G0246 |
Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education |
15 |
13 |
$99.16 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
15 |
13 |
$78.31 |
| 81002 |
|
14 |
14 |
$35.68 |
| 97802 |
|
15 |
13 |
$24.48 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,513 |
1,356 |
$0.00 |